文献速递生殖医学

胚胎移植培养基中添加透明质酸在供卵周期与自体卵母细胞周期中的效果:系统综述与Meta分析

The effect of hyaluronic acid in embryo transfer media in donor oocyte cycles and autologous oocyte cycles: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod · 2022-01-01

该系统综述与Meta分析纳入15项随机对照试验共4686名参与者,评估胚胎移植培养基中添加透明质酸(HA)对妊娠结局的影响。在自体卵母细胞周期中,功能性HA浓度(0.5 mg/ml)使活产率从32%升至39%(RR 1.22,95%CI 1.11-1.34),临床妊娠率和多胎妊娠率分别增加5%和8%。在供卵周期中,HA添加对活产和临床妊娠显示 little effect(原文表述),证据质量低。

要点

  • 自体卵母细胞周期中,功能性HA浓度(0.5 mg/ml)使活产率从32%升至39%(RR 1.22,95%CI 1.11-1.34,中等质量证据)。
  • 自体卵母细胞周期中,HA富集培养基使临床妊娠率增加5%(RR 1.11,95%CI 1.04-1.18),多胎妊娠率增加8%(RR 1.49,95%CI 1.27-1.76)。
  • 供卵周期中,HA添加对活产和临床妊娠显示 little effect(原文表述),证据质量低。

核心结论

  • 最佳可用证据表明,在自体卵母细胞周期中,胚胎移植培养基中添加HA具有临床获益。
  • 在供卵周期中未观察到该效果,可能提示供卵与自体卵母细胞之间存在内在差异或统计效能不足。
  • 在自体卵母细胞周期中,HA添加联合单胚胎移植政策可能获得最佳组合,提高临床妊娠率和活产率而不增加多胎妊娠风险。

研究设计与样本

  • 系统综述与Meta分析,检索Cochrane妇产科与生育组试验注册库、CENTRAL、MEDLINE、Embase和PsycINFO等数据库(截至2020年1月8日)。
  • 纳入比较功能性HA浓度(0.5 mg/ml)与无或低HA浓度(0.125 mg/ml)胚胎移植培养基的随机对照试验,要求有供卵和自体卵母细胞的单独数据。
  • 共分析15项研究,总计4686名参与者。
  • 两名综述作者独立筛选试验、提取数据并使用Cochrane偏倚风险评估工具评价纳入研究。
  • 使用GRADE标准生成结果总结表,并将证据质量判断纳入每个结局的报告结果中。

主要发现

  • 自体卵母细胞周期中,活产率从32%升至39%(RR 1.22,95%CI 1.11-1.34;9项研究,3215名参与者,I²=39%,中等质量证据,NNT 14)。
  • 自体卵母细胞周期中,HA富集培养基使临床妊娠率增加5%(RR 1.11,95%CI 1.04-1.18;13项研究,4014名参与者,I²=0%,中等质量证据,NNT 21)。
  • 自体卵母细胞周期中,HA富集培养基使多胎妊娠率增加8%(RR 1.49,95%CI 1.27-1.76;5项研究,2400名参与者,I²=21%,中等质量证据,NNH 13)。
  • 供卵周期中,HA添加对活产显示 little effect(RR 1.12,95%CI 0.86-1.44;2项研究,317名参与者,I²=50%,低质量证据)。
  • 供卵周期中,HA添加对临床妊娠显示 little effect(RR 1.06,95%CI 0.97-1.28;3项研究,351名参与者,I²=23%,低质量证据)。

关键数值与推荐

  • 功能性HA浓度定义为0.5 mg/ml,对照为无或低HA浓度(0.125 mg/ml)。
  • 自体卵母细胞周期中,活产率32%升至39%,RR 1.22(95%CI 1.11-1.34),中等质量证据。
  • 自体卵母细胞周期中,临床妊娠率增加5%,RR 1.11(95%CI 1.04-1.18),中等质量证据。
  • 自体卵母细胞周期中,多胎妊娠率增加8%,RR 1.49(95%CI 1.27-1.76),中等质量证据。
  • 供卵周期中,活产RR 1.12(95%CI 0.86-1.44)和临床妊娠RR 1.06(95%CI 0.97-1.28),均为低质量证据。

临床怎么用

  • 在自体卵母细胞IVF周期中,胚胎移植培养基添加功能性HA浓度(0.5 mg/ml)可提高临床妊娠率、活产率和多胎妊娠率(中等质量证据)。
  • 在供卵周期中,HA添加对活产和临床妊娠显示 little effect(原文表述),证据质量低。
  • 作者认为,在自体卵母细胞周期中HA添加联合单胚胎移植政策可能获得最佳组合,提高临床妊娠率和活产率而不增加多胎妊娠风险。
  • 供卵周期多胎妊娠和两组总不良事件信息不足,无法得出结论。

局限性

  • 关于供卵周期单独数据的研究有限。
  • 关于卵母细胞质量的信息有限。
  • 三分之一纳入研究未包含主要结局活产率。
  • 供卵周期多胎妊娠和两组总不良事件信息不足,无法得出结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does the addition of hyaluronic acid (HA) to embryo transfer medium improve pregnancy outcomes in both autologous and oocyte donation IVF cycles? SUMMARY ANSWER: The best available evidence indicates that the addition of HA to embryo transfer medium is clinically beneficial in cycles with autologous oocytes. WHAT IS KNOWN ALREADY: There is a known clinical benefit of HA addition to embryo transfer media but it is not known if HA affects donor and autologous oocyte cycles differently. STUDY DESIGN, SIZE, DURATION: A systematic review with meta-analysis was performed. The Cochrane Gynaecology and Fertility Group Trials Register, CENTRAL via Cochrane Register of Studies Online (CRSO), MEDLINE, Embase and PsycINFO electronic databases (until 8 January 2020) were searched for randomized controlled trials (RCTs) examining the effect of HA in embryo transfer medium on pregnancy outcomes. PARTICIPANTS/MATERIALS, SETTING, METHODS: RCTs with separate donor and autologous oocyte data that compared embryo transfer medium with functional HA concentrations (0.5 mg/ml) to those containing no or low HA concentrations (0.125 mg/ml) were included. Two review authors independently selected trials for inclusion, extracted data and assessed the included studies using the Cochrane risk of bias assessment tool. Pooled risk ratios and 95% CIs were calculated. A summary of findings table was generated using Grading of Recommendations, Assessment, Development and Evaluation criteria. Judgements about evidence quality were justified and incorporated into the reported results for each outcome. MAIN RESULTS AND THE ROLE OF CHANCE: Fifteen studies, totalling 4686 participants, were analysed. In autologous oocyte cycles, live birth increased from 32% to 39% when embryo transfer media contained functional HA concentrations (risk ratio (RR) 1.22, 95% CI 1.11-1.34; nine studies, 3215 participants, I2 = 39%, moderate-quality evidence (number needed to treat (NNT) 14). HA-enriched media increased clinical pregnancy and multiple pregnancy rates by 5% and 8%, respectively (RR 1.11, 95% CI 1.04-1.18; 13 studies, 4014 participants, I2 = 0%, moderate-quality evidence, NNT 21) and (RR 1.49, 95% CI 1.27-1.76; 5 studies, 2400 participants, I2 = 21%, moderate-quality evidence, number needed to harm 13). Conversely, in donor oocyte cycles, HA addition showed little effect on live birth and clinical pregnancy (RR 1.12 95% CI 0.86-1.44; two studies, 317 participants, I2 = 50%, low-quality evidence) and (RR 1.06, 95% CI 0.97-1.28; three studies, 351 participants, I2 = 23%, low-quality evidence). There was insufficient available information on multiple pregnancy in donor oocyte cycles and on total adverse effects in both groups to draw conclusions. LIMITATIONS, REASONS FOR CAUTION: There were limited studies with separate data on donor oocyte cycles and limited information on oocyte quality. Additionally, one-third of the included studies did not include the main outcome, live birth rate. WIDER IMPLICATIONS OF THE FINDINGS: There is a moderate level of evidence to suggest that functional HA concentration in embryo transfer medium increases clinical pregnancy, live birth and multiple pregnancy rates in IVF cycles using autologous oocytes. This effect was not seen in donor oocyte cycles, indicating either intrinsic differences between donor and autologous oocytes or lack of statistical power. The combination of HA addition to transfer media in cycles using autologous oocytes and a single embryo transfer policy might yield the best combination, with higher clinical pregnancy and live birth rates without increasing the chance of multiple pregnancies. STUDY FUNDING/COMPETING INTEREST(S): No financial assistance was received. The authors have no competing interests. REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Heymann D, Vidal L, Shoham Z, et al. The effect of hyaluronic acid in embryo transfer media in donor oocyte cycles and autologous oocyte cycles: a systematic review and meta-analysis. Hum Reprod. 2022. PMID: 35595183. doi:10.1093/humrep/deac097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。